New: Introducing the Finviz Crypto Map

Pacira BioSciences

Contributing Author

Recent Articles by Pacira BioSciences

Jul-24	Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025 PCRX GlobeNewswire
Jul-22	Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts PCRX GlobeNewswire
Jul-03	Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PCRX GlobeNewswire
Jun-18	Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient's Journey to Pain Relief and Innovation in Care at BIO 2025 PCRX GlobeNewswire
Jun-11	Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee PCRX GlobeNewswire
Jun-05	Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PCRX GlobeNewswire
May-15	Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee PCRX GlobeNewswire
May-14	Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences PCRX GlobeNewswire
May-08	Pacira BioSciences Reports First Quarter 2025 Financial Results PCRX GlobeNewswire
May-06	Pacira BioSciences to Present 3-Year Safety and Efficacy Data of PCRX-201 Following Single Intra-Articular Injection for Moderate-to-Severe Knee Osteoarthritis PCRX GlobeNewswire
May-02	Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis PCRX GlobeNewswire

Affiliate • Advertise • Theme Settings • Contact • Blog • Help • Privacy • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.